S&P 5007,785.76▼0.2% Nasdaq26,729.16▼0.3% Dow53,732.41▼0.2% Russell 2K3,068.42▲0.5% 10-Yr4.70%+6bp VIX14.25−0.38 WTI$82.40▲1.4% Gold$4,432.00▲1.6% EUR/USD1.157▲0.4% BTC$77,322▲0.3% Nikkei68,309▲1.2%
At close · Fri, Aug 14, 2026
Daily Market Updates.

US Markets

Home›US Markets›M&A & Deals›AstraZeneca and Bristol-Myers Squibb tie-up talks roil…

AstraZeneca and Bristol-Myers Squibb tie-up talks roil shares

Bristol-Myers Squibb stock rose while AstraZeneca shares fell as reports of potential deal discussions spread.

Reported · Written up by our desk · M&A & Deals

MarketWatch reports that shares of AstraZeneca and Bristol-Myers Squibb moved sharply on Monday amid reports of tie-up talks.

According to MarketWatch, Bristol-Myers Squibb was jumping while AstraZeneca was slumping.

The report notes analysts are focused on the rationale for a potential combination between the two pharmaceutical companies, beyond the immediate stock reaction.

← Newer storyBithumb lays out roadmap for 2028 IPO after K-IFRS shift

More like this

US MarketsNVIDIA partners with Cloverleaf to expand U.S. AI data center infrastructure
US MarketsFormer Abercrombie CEO Michael Jeffries deemed competent for sex trial
US MarketsUnited CEO Scott Kirby pitches future expansion and AI plans
US MarketsUGI jumps after KKR reportedly makes $42.50 per-share bid
US MarketsKFC closes more than 300 US restaurants as locations underperform

Sources

MarketWatchAstraZeneca reported tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.
MarketWatchAstraZeneca reported tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.